SCA
SRNE

Snowden Capital Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Snowden Capital Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-550
Closed -$2K – 2199
2021
Q4 		$2K Buy
+550
New +$2K ﹤0.01% 1904